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[1571] 
Creating a Clearinghouse to Evaluate 
Environmental Risks to Fetal Development 
Kate E. Bloch  
In this Article, the Author explores current challenges to accessing and evaluating 
information about environmental risks to fetal development. She investigates these 
challenges within the context of the existing regulatory framework for environmental 
risks. As a result of this analysis, she highlights the need for and proposes creating an 
independent non-profit umbrella organization—a clearinghouse—to collect, distill, 
interpret, and make accessible the research on environmental threats to fetal development 
and to apply that research to evaluating relevant U.S. policy. The Author defines broadly 
the research on fetal development that lies within the charge of the clearinghouse to 
include not only research about chemical toxicant risks but also research involving 
environmental risks related to criminal and social justice policies.  
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Introduction 
I averted my eyes from the needle. It was the biggest one I had ever 
seen—about five inches long.1 But this hollow tube designed for extracting 
cells from amniotic fluid would play a key role in answering many of my 
most pressing questions about the fetus I was carrying. Combined with an 
earlier ultrasound, it would supply critical information about the health 
of my child’s developing brain. Neuroscience, genetics, and the related 
field of epigenetics furnish heretofore undreamed of insights into the 
development of the human brain. This evolving understanding also sheds 
increasing light on the toxic chemicals and the behaviors that may 
profoundly alter or damage the fetal brain. As our understanding of the 
threats that can undermine healthy brain development and functioning 
grows, the question of regulating and reducing such damaging threats 
assumes greater prominence and urgency.2 
 
 1. Amniocentesis needles commonly range from 90 mm to 150 mm, or approximately 3.5 inches 
to 5.9 inches, in length. See, e.g., Amniocentesis Needles with Stylets, LabIVF, http://www.labivf.com/ 
index.cfm?GPID=93 (last visited July 1, 2012 by the editorial staff; this website reference and those in 
the notes that follow were last visited by the Author on varying dates on or before June 23, 2012). 
 2. See Philippe Grandjean et al., The Faroes Statement: Human Health Effects of Developmental 
Exposure to Chemicals in Our Environment, 102 Basic & Clinical Pharmacology & Toxicology 73, 
75 (2007) (“The accumulated research evidence suggests that prevention efforts against toxic 
exposures to environmental chemicals should focus on protecting the embryo, foetus and small child 
as highly vulnerable populations. Given the ubiquitous exposure to many environmental chemicals, 
there needs to be renewed efforts to prevent harm.”); see also Michael P. Wilson & Megan R. 
Schwarzman, Toward a New U.S. Chemicals Policy: Rebuilding the Foundation to Advance New 
Science, Green Chemistry, and Environmental Health, 117 Envtl. Health Persp. 1202, 1203–04 (2009). 
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Imagine a child is born who suffers from impaired language 
development, attention deficits, visual-spatial deficits, impaired fine motor 
function, and verbal memory deficits. Imagine too that the child’s mother 
had followed all of the recommendations on the U.S. Food and Drug 
Administration (“FDA”) and the U.S. Department of Health and Human 
Services (“HHS”) websites during her pregnancy. This child’s impairments 
do not stem from prenatal exposure to illegal drugs. In fact, her mother 
was scrupulously careful to avoid all over-the-counter and prescription 
medications. She exercised regularly and worked hard to maintain the diet 
recommended by the FDA and the HHS. The mother suffered from no 
illnesses during her pregnancy and consumed no alcohol. Her occupation 
did not expose her to any unusual levels of toxic chemicals. Neither she 
nor the father has a family history of similar difficulties. Her physician is 
at a loss to suggest any possible explanation for the child’s limitations.3 
The mother, who is contemplating having a second child, begins an 
extensive search for possible explanations. She discovers that research 
has associated the particular collection of limitations from which her 
child suffers with “[c]hronic, low-dose prenatal MeHg [methylmercury] 
exposure from maternal consumption of fish.”4 But she was careful not to 
consume more than the FDA-recommendation of up to six ounces per 
week of albacore tuna during her pregnancy.5 With a bit of digging, she 
unearths a 2001 report from the Environmental Working Group about 
the contamination of fish by methylmercury. The report contends that 
 
Research over the last several decades has demonstrated that the human brain’s plasticity can enable 
remarkable self-repair or compensation in functionality after injury. See, e.g., Norman Doidge, The 
Brain That Changes Itself (2007). Still, “[t]he brain is particularly sensitive to toxic exposures 
during development, which involves a complex series of steps that must be completed in the right 
sequence and at the right time.” Grandjean et al., supra, at 74. Perhaps some types of damage are 
much more difficult to repair, or perhaps we do not yet know how to invoke the brain’s repair 
functions for those types of injuries. 
 3. My hypothetical physician is not familiar, at least initially, with the research correlating the 
child’s deficits with possible methylmercury exposure. Many physicians, of course, could or would be. 
 4. Comm. on the Toxicological Effects of Methylmercury, Nat’l Res. Council, 
Toxicological Effects of Methylmercury 4 (2000) (“Chronic, low-dose prenatal MeHg exposure 
from maternal consumption of fish has been associated with more subtle end points of neurotoxicity in 
children. Those end points include poor performance on neurobehavioral tests, particularly on tests of 
attention, fine-motor function, language, visual-spatial abilities (e.g., drawing), and verbal memory.”); 
see Gideon Koren et al., Fetal Risks of Environmental Chemicals: The Motherisk Approach to the 
Organic Mercury-Fish Consumption Scare, 63 Hastings L.J. 1605, 1605–07 (2012) (“While fish is rich 
in essential nutrients and women are encouraged to consume fish products, fish may contain 
methylmercury, which is an established neurotoxin to the fetus. . . . [S]ome species of fish contain 
methylmercury in sufficient amounts to cause adverse neurodevelopmental effects. . . . Methylmercury 
crosses the placenta and is found at higher concentrations in fetal blood than in the mother’s blood.” 
(citations omitted)). 
 5. U.S. Food & Drug Admin. & U.S. Envtl. Prot. Agency, EPA-823-R-04-005, What You 
Need to Know About Mercury in Fish and Shellfish 2 (2004) (“[Y]ou may eat up to 6 ounces (one 
average meal) of albacore tuna per week.”).  
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“[t]en percent of American women enter pregnancy with elevated 
methylmercury levels, and current FDA safeguards, which are based on 
average exposures, do almost nothing to protect these high exposure 
pregnancies.”6 She intensifies her search, looking for other countries’ 
approaches to advising pregnant women about methylmercury exposure. 
She finds guidelines from Sweden on environmental risks during 
pregnancy.7 These address methylmercury and fish consumption as well, 
but they contend that, “[a]ccording to the recommendations of the 
Swedish National Food Administration . . . , pregnant and breastfeeding 
women, as well as women planning a pregnancy, should not eat . . . tuna 
more than at the most 2–3 times/year.”8 She also learns that according to 
the National Academy of Sciences Committee on the Toxicological 
Effects of Methylmercury, “[a]vailable consumption data and current 
population and fertility rates indicate that over 60,000 newborns annually 
might be at risk for adverse neurodevelopmental effects from in utero 
exposure to MeHg.”9 
The mother persuades her physician to test her hair for 
methylmercury.10 Imagine that the test reveals elevated levels of 
methylmercury dating back to six months before her first pregnancy. The 
physician cannot ascertain whether these elevated methylmercury levels 
caused her child’s difficulties. The physician even points to a large study 
that did not find a correlation between low doses of methylmercury and 
learning deficits.11 But one can imagine the mother lamenting how easy it 
would have been to consume her omega-3 fatty acids and protein in the 
months before and during her pregnancy from some source other than 
 
 6. Jeremiah Baumann et al., Envtl. Working Grp., Brain Food: What Women Should Know 
About Mercury Contamination of Fish 3–4 (2001). This Brain Food report references a pre-2004 
FDA allowance of twelve ounces of any type of fish (except four banned types) per week. Id. at 4. The 
current FDA recommendation continues to ban the four types of fish and to advise pregnant women 
to “[e]at up to 12 ounces (2 average meals) a week of a variety of fish and shellfish that are lower in 
mercury.” U.S. Food & Drug Admin., supra note 5. The current twelve ounce recommendation 
includes canned light tuna, but recommends only up to six ounces of albacore tuna per week. Id. In 
contrast, the Baumann Brain Food report contends that the “FDA must restrict consumption of 
[certain] fish to no more than one meal per month, for all species combined: [including] [c]anned 
tuna.” Baumann et al., supra, at 4. 
 7. See generally Lars Gerhardsson & Linnéa Lillienberg, Sahlgrenska Univ. Hosp., 
Guidelines for Assessment of Working and Environmental Risks During Pregnancy (2009). 
 8. Id. at 3. 
 9. Comm. on the Toxicological Effects of Methylmercury, supra note 4, at 325. 
 10. Colleen Moore, Children and Pollution: Why Scientists Disagree 43 (2009) (“The 
amount of mercury a person has absorbed can be measured in hair.”). 
 11. See Comm. on the Toxicological Effects of Methylmercury, supra note 4, at 4 (“Of three 
large epidemiological studies, two studies—one conducted in the Faroe Islands and one in New 
Zealand—found such associations, but those effects were not seen in a major study conducted in the 
Seychelles islands.”); id. at 1 (“Consumption of contaminated fish is the major source of human 
exposure to MeHg in the United States.”). 
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albacore tuna—perhaps a source like shrimp or nuts.12 One can further 
imagine the mother thinking that if she had just known about the risks, 
she might have saved her child the daily struggles she now faces. 
The mother will never know whether her daughter’s limitations 
resulted from exposure to methylmercury in fish, this exposure in 
combination with other factors, or from something else entirely. What this 
hypothetical does suggest is that the information on which the mother 
could have based a more informed decision was scattered across the 
Internet from sources she, as a layperson, would have had to unearth and 
evaluate.13 Moreover, by relying on the official websites of the FDA and 
the HHS, she didn’t realize that perhaps she should have been looking 
elsewhere for studies and guidelines on environmental hazards.14 
 
 12. Alternatively, one scholar has recommended that “routine gestational supplementation with 
purified fish oil or microalgae oil in addition to regular ALA [alpha linolenic acid] intake should be 
studied as a potential means to secure the benefits without the risks: adequate nutrition without 
toxicant exposure.” Stephen J. Genuis, To Sea or Not to Sea: Benefits and Risks of Gestational Fish 
Consumption, 26 Reprod. Toxicology 81, 84 (2008). For a study discussing the benefits to fetuses of 
fish consumption generally in protecting against harm from ambient fine particulates, see Wieslaw 
Jedrychowski et al., Higher Fish Consumption in Pregnancy May Confer Protection Against the 
Harmful Effect of Prenatal Exposure to Fine Particulate Matter, 56 Annals Nutrition & 
Metabolism 119, 123 (2010) (“[O]ur study . . . did not collect information on the exact amount and 
type of fish consumed by the study participants.”). 
 13. In Dr. Gideon Koren’s article for this Symposium, he notes with respect to pregnant women’s 
consumption of fish and the methylmercury concern that “[t]here has been broad media coverage on 
the topic, presenting contradictory information regarding the benefits and risks of fish consumption. 
Contradictory information presented simultaneously can lead to confusion in the public that includes 
skepticism about the media source, anxiety, and stress.” Koren et al., supra note 4, at 1607–08 
(footnotes omitted). In some cases, a mother’s health care provider would, of course, probably be 
helping to search, parse, and interpret the research. 
 14. For an article analyzing information on federal advisories on methylmercury and U.S. 
consumption of canned tuna, see Beth Pallo & Marlene Barken, The Domestic and International 
Dimensions of Methylmercury Contamination in Tuna: An Analysis of the Efficacy of the Fish 
Advisory Standards of Two Federal Agencies, 18 Res. Soc. Probs. & Pub. Pol’y 179 (2010) (arguing 
that current federal advisories about canned tuna are inadequate). Consumer Reports has also 
conducted research on canned tuna. See Mercury in Canned Tuna Still a Concern: New Tests Reinforce 
a Need for Some People to Limit Consumption, Consumer Reports, http://www.consumerreports.org/ 
cro/magazine-archive/2011/january/food/mercury-in-tuna/overview/index.htm (last visited July 1, 2012) 
(“Children and women of childbearing age can easily consume more mercury than the Environmental 
Protection Agency considers advisable simply by eating one serving of canned white tuna or two 
servings of light tuna per week.”). Consumer Reports recommends, as a precautionary measure, that 
pregnant women not consume tuna at all. Id.  
For a study examining fish consumption and levels of awareness of cautionary advisories 
about fish consumption, see generally Elana Silver et al., Fish Consumption and Advisory Awareness 
Among Low-Income Women in California’s Sacramento-San Joaquin Delta, 104 Envtl. Res. 410 
(2007). The authors of this study reported that more “than one-quarter of women (29%) [in the study] 
exceeded the joint FDA/EPA advisory limit via a combination of sport and commercial fish 
consumption.” Id. at 416. The authors also found that “pregnant women were 2.2 times more likely to 
consume fish within the joint FDA/EPA advisory limit . . . than non-pregnant women.” Id. With 
respect to awareness of fish consumption advisories, the authors reported that almost “half of the 
study participants (45%) had general advisory awareness,” id., meaning they answered affirmatively 
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But even if the hypothetical mother described above had been 
aware of the potential hazards for women consuming methylmercury 
during pregnancy, particularly with an already elevated methylmercury 
exposure, research on other potential hazards to her developing fetus 
might still have been at too early a stage to have provoked media 
attention, triggered an FDA caution, or otherwise entered into the 
general public consciousness. Moreover, even with early warning, some 
hazards, such as polychlorinated biphenyls, which were once used in 
many common items like paints and varnishes and sealants, may so 
broadly permeate our environment that pregnant women cannot 
reasonably avoid them without external regulation of those hazards.15 In 
fact, researchers in one empirical study extracted blood from the 
umbilical cords of newborns and detected 287 pollutants and synthetic 
chemicals, suggesting the extent to which toxic chemicals permeate our 
environment.16 Of those, the researchers opined: “180 cause cancer in 
humans or animals, 217 are toxic to the brain and nervous system, and 
208 cause birth defects or abnormal development in animal tests. The 
dangers of pre- or post-natal exposure to this complex mixture of 
carcinogens, developmental toxins and neurotoxins have never been 
studied.”17 
 
when asked if they were “aware of any health warnings about eating fish or shellfish for women of 
childbearing age.” Id. at 412. A recent study by FDA researchers, using a national sample of women, 
found that, in their pregnant, postpartum, and control groups of women, a “majority of all 3 groups of 
women were aware of mercury as a problem in food and that virtually all women in all 3 groups were 
consuming fish at levels consistent with the 2004 joint FDA/EPA advice for not consuming too much 
or certain types of fish. However, most women were not eating the amount of low mercury fish 
recommended . . . .” Amy M. Lando, et al., Awareness of Methylmercury in Fish and Fish 
Consumption Among Pregnant and Postpartum Women and Women of Childbearing Age in the United 
States, 116 Envtl. Res. 85, 90 (2012). 
 15. Moore, supra note 10, at 68–103. “PCBs are extremely stable chemicals. Like mercury, they 
are distributed around the globe and biomagnify up the food chain.” Id. at 68. PCBs have been used in 
a variety of substances including varnishes, paint, electrical transformers, flame proofing of textiles, 
sealants, and plasticizers. Id. at 70 (citing Martin G. Broadhurst, Use and Replaceability of Polychlorinated 
Biphenyls, 1 Envtl. Health Persp. 81 (1972); J. Wister Meigs et al., Chloracne from an Unusual 
Exposure to Arochlor, 154 JAMA 1417 (1954)); see Jane Houlihan et al., Body Burden: The 
Pollution in Newborns 33–34 (2005) (“[F]etal exposure to industrial chemicals is contributing to 
adverse health effects in the human population. This is cause for concern. But experience shows us 
that it is never too late to take action. Blood levels of PCBs and pesticides like DDT are lower today 
than 30 years ago when they were banned.”). 
 16. Houlihan et al., supra note 15, at 13–14. 
 17. Id. Research in recent decades has enhanced available information and resources that relate 
to potential environmental threats to children more generally. See, e.g., Tracey Woodruff et al., U.S. 
Envtl. Prot. Agency, EPA 240-R-03-001, America’s Children and the Environment: Measures of 
Contaminants, Body Burdens, and Illnesses (2003); Pediatric Environmental Health Specialty 
Units: A Network of Experts in Children’s Environmental Health, PEHSU, 
http://aoec.org/pehsu/aboutus.html (last visited July 1, 2012) (“The Pediatric Environmental Health 
Specialty Units (PEHSU) are a source of medical information and advice on environmental conditions 
that influence children’s health. PEHSU are academically based, typically at university medical 
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This Article reflects upon the insights of physicians, medical 
researchers, and legal policy analysts who gathered at a recent Symposium 
to discuss the current state of research on environmental threats to the 
fetal brain as well as approaches to regulating them.18 From their collective 
insights as well as research from individuals and organizations focused on 
various facets of the regulation question, this Article highlights the need 
for and proposes developing an umbrella entity charged explicitly with 
(1) comprehensive data gathering and analysis, (2) evaluation of U.S. 
legal approaches and policy in the context of the relevant evolving 
research, and (3) information sharing about risks and proposed responses 
to environmental threats to the fetal brain and to fetal development 
more generally.19 
A number of federal and state agencies, as well as many independent 
and industry researchers, currently study and address potential risks and 
sometimes propose policy changes in this field. But the varied missions of 
these individuals and entities, the difficulty in accessing and interpreting 
data, and the variety of audiences to whom these data and policies are 
relevant suggest that an independent non-profit umbrella entity focused 
 
centers, and are located across the United States, Canada and Mexico. These PEHSU form a network 
that is capable of responding to requests for information throughout North America and offering 
advice on prevention, diagnosis, management, and treatment of environmentally-related health effects 
in children.”). 
 18. University of California, Hastings College of the Law, Law & Policy of the Developing Brain: 
Neuroscience from Womb to Death, Panel #1: Assaults on Prenatal and Early Childhood Brain 
Development: What Can Be Done? Limits on Autonomy and Government Regulation (Feb. 10, 
2012). The panelists were Dr. Khiara Bridges, Dr. Gideon Koren, Dr. Megan Schwarzman, Dr. Mishka 
Terplan, and Dr. Tracey Woodruff. 
 19. Scholars in the realm of public health have emphasized the need for increased awareness of 
the risks of environmental toxicants on fetal development. See Elizabeth Harrison et al., Johns 
Hopkins Women’s & Children’s Health Pol’y Ctr., Envtl. Toxicants and Maternal and Child 
Health: An Emerging Public Health Challenge 1 (2009) (“Widespread awareness of 
environmental toxicants and their effects on reproductive and perinatal outcomes is essential in order 
to decrease preconception and prenatal exposure.”). The authors of the same article also report that 
“[t]he heterogeneity of toxicants poses a challenge in educating women about risk and how to reduce 
exposures. For example, a substantial exploration of the Internet in 2007 did not reveal any national, 
state, or local organized efforts specifically targeting pregnant and/or childbearing age women about 
pesticides and how to reduce their exposures.” Id. at 4; see Holly A. Grason & Dawn P. Misra, 
Reducing Exposure to Environmental Toxicants Before Birth: Moving from Risk Perception to Risk 
Reduction, 124 Pub. Health Rep. 629, 634 (2009) (The authors contend that there “appears to be 
general consensus that clinicians are not well-versed on the subject of environmental exposures.”) 
[hereinafter Grason & Misra, Reducing Exposure]. For useful charts describing available Internet 
resources as of 2007 on “Environmental Hazards Relevant to Reproductive and Perinatal Health,” see 
Holly Grason & Dawn Misra, Summary Tables: Internet-Posted Information on Environmental 
Hazards Relevant to Reproductive and Perinatal Health, Johns Hopkins Bloomburg Sch. of Pub. 
Health, http://www.jhsph.edu/wchpc/publications/perinatal_environ_hazards_web.pdf (last visited 
July 1, 2012) (“The . . . tables describe findings from a systematic search of web-available materials 
conducted between June and August 2007 using the search terms ‘pregnancy,’ ‘pregnant women,’ 
‘reproductive health,’ ‘environmental exposures,’ ‘environmental hazards,’ and ‘environmental 
toxins.’”) [hereinafter Grason & Misra, Summary Tables]. 
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specifically on the question of risks and responses to environmental threats 
to fetal development could bring greater accessibility and coherence to the 
evaluation of risks and the creation of informed decisions and cohesive 
policy responses.20 
In Part I, this Article surveys a few of the sources of potential 
environmental threats to the fetal brain. Although the focus is on the fetal 
brain, the fetus more generally is at risk from many of the same 
environmental toxicants. Thus, the Article ultimately proposes a 
clearinghouse that addresses environmental threats not only to the fetal 
brain but to overall fetal development. Part II canvasses current structural 
avenues of regulation. Part III speaks to the challenges of maternal self-
regulation. Part IV concludes with a proposal for a think tank 
clearinghouse, The Clearinghouse to Evaluate Environmental Risks to 
Fetal Development (the “Clearinghouse”), to collect, evaluate, and share 
the research about environmental threats to fetal development. Part IV 
also raises a number of the concerns that such a clearinghouse might 
engender. 
I.  Threats to the Fetal Brain 
Environmental threats to fetal brain development and subsequent 
functioning range from those that have been extensively researched and 
documented, to those currently under substantial scrutiny, to those not 
yet under serious scrutiny. This discussion about these threats is not 
meant to be exhaustive.21 Instead, it aims to highlight the spectrum of 
research and how this spectrum reveals a need for a more integrated and 
comprehensive approach to gathering, evaluating, and presenting the 
data on potential damage-causing agents to fetal health. 
Toxic chemicals such as lead and methylmercury find their place in 
the first category of extensively researched toxicants. But that was not 
 
 20. For a discussion of some of the organizations focused on environmental threats to human 
health, see infra notes 101–119 and accompanying text. The research reported in Dr. Gideon Koren’s 
Article in this Symposium issue speaks to the need for a respected interpreter of studies and 
information on methylmercury and pregnancy. Dr. Koren reports on research that his organization, 
Motherisk, conducted with women who had contacted Motherisk for advice about fish consumption 
during pregnancy during 2006–2007. Koren et al., supra note 4, at 1608 (“The Motherisk Program 
provides information and counseling services that assess maternal and fetal risks following exposure to 
medications, recreational drugs, and various environmental chemicals during pregnancy and 
lactation.”). For a more detailed discussion of Dr. Koren’s research, see infra notes 86–87 and 
accompanying text. Motherisk evaluates research on the impact of radiation and diseases on fetal 
health, research beyond chemical toxicants. The charge of the Clearinghouse discussed in Part IV 
could include the gathering and evaluation of such research. 
 21. To the contrary, this Article points out only a few of the many potential or confirmed 
environmental (primarily chemical) threats to the fetal brain. This Article also does not address 
inadvertent or intentional infliction of violence on the fetal brain. 
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always the case, and debate about their toxicity in low levels persists.22 
Alcohol and tobacco use during pregnancy similarly fall into the 
extensively researched category. Alcohol’s effect on pregnancy, in 
particular that ingestion of alcohol during pregnancy is the cause of Fetal 
Alcohol Spectrum Disorders, now represents a well-documented and 
accepted tenet of neurobiology.23 These disorders are marked by findings 
that range from atypical facial features, to learning disabilities and poor 
coordination, to low IQ, and to heart, kidney, and bone problems.24 
Similarly, the effects of cigarette smoke on fetal development have 
received extensive study.25 Studies over the years have repeatedly 
associated smoking during pregnancy with fetal morbidity, such as low 
birth-weight babies, as well as fetal mortality.26 
Even for extensively researched hazardous chemicals, the road to 
serious scrutiny and significant regulation has commonly been paved with 
delay and political hurdles, particularly when an industry producing or 
disseminating the toxicant is fundamental to the economy or is otherwise 
highly politically influential.27 Scholars point, for example, to the decades-
long process that was required to ban leaded gasoline.28 But overcoming 
 
 22. See Moore, supra note 10, at 29, 3–36 (“Scientists still disagree about low-level lead exposure, 
in spite of all the evidence that it harms children’s development. Scientists do agree that lead in high 
doses is toxic.”); Amy Norton, No “Safe” Lead Level Seen for Fetal Brain, Reuters Health (Jan. 19, 
2006), http://www.ewg.org/news/no-safe-lead-level-seen-fetal-brain. 
 23. Facts About FASDs, Ctrs. for Disease Control & Prevention, http://www.cdc.gov/ncbddd/ 
fasd/facts.html (last visited July 1, 2012). (“[Fetal Alcohol Spectrum Disorders] are caused by a woman 
drinking alcohol during pregnancy.”); see Fetal Alcohol Syndrome, Mayo Clinic, 
http://www.mayoclinic.com/health/fetal-alcohol-syndrome/DS00184/DSECTION=risk-factors (last visited 
July 1, 2012) (“Although doctors aren’t sure how much alcohol you’d have to drink to place your baby 
at risk, they do know that the more you drink, the greater the chance of problems. Because there’s no 
known safe amount of alcohol consumption during pregnancy, don’t drink alcohol if you are or think 
you are pregnant or you’re attempting to become pregnant. You could put your baby at risk even 
before you realize you’re pregnant.”).  
 24. Facts About FASDs, supra note 23.  
 25. See, e.g., Highlights: Impact on Unborn Babies, Infants, Children, and Adolescents, Ctrs. for 
Disease Control & Prevention, http://www.cdc.gov/tobacco/data_statistics/sgr/2004/highlights/ 
children/index.htm (last visited July 1, 2004) (“Research has shown that women’s smoking during 
pregnancy increases the risk of pregnancy complications, premature delivery, low birth-weight infants, 
stillbirth, and sudden infant death syndrome (SIDS).”). 
 26. See, e.g., Hamisu M. Salihu & Roneé E. Wilson, Epidemiology of Prenatal Smoking and 
Perinatal Outcomes, 11 Early Hum. Dev. 713, 713 (2007) (“[P]renatal smoking remains a common 
habit and accounts for a significant proportion of fetal morbidity and mortality through both a direct 
(fetal) and an indirect (placental) effect.”); Highlights, supra note 25. 
 27. See, e.g., Moore, supra note 10, at 3–36 (describing the influence of industry and/or industry-
funded scientific research on the efforts to ban tetraethyl lead in gasoline). 
 28. Id. On the issue of the delay in implementing programs for reducing lead exposure for 
children, see Philippe Grandjean & Phillip J. Landrigan, Developmental Neurotoxicity of Industrial 
Chemicals, 368 Lancet 2167, 2167 (2006) (“Previous evidence-based programmes of exposure 
prevention, such as those directed against children’s exposure to lead, have been highly successful, 
although they were initiated after substantial delay.”). 
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the hurdles and producing useful regulations can have a remarkable 
impact. Scholars report a “90% reduction in childhood blood-lead 
concentrations follow[ing] the termination of lead additives in petrol.”29  
Beyond hurdles to regulation erected or fostered by industry, 
regulation also sometimes conflicts with consumer demand and 
autonomy. For example, alcohol consumption and smoking are legal 
activities for adults. Depriving adults of access to those activities raises 
autonomy and discrimination concerns, particularly if the deprivation is 
specifically linked to a woman’s pregnancy.30 
Cocaine might also fall within the category of environmental threats 
that have already been subject to extensive research.31 Controversy about 
the effects of cocaine on fetal health, however, remains. In an open-access, 
peer-reviewed, digital discussion of the effects of cocaine on the fetal 
brain, Dr. Steven E. Hyman explains: 
Multiple studies have attempted to identify the effects of cocaine and 
other commonly abused drugs on fetal brain development and 
behavior in clinical populations. The attribution of risk to specific drugs 
remains challenging, however, because women addicted to cocaine often 
use other illegal drugs as well as alcohol and tobacco. Moreover, they 
tend to have poor nutrition, low levels of prenatal care, and other 
problems that confound analysis.32 
But Dr. Hyman concludes that “[o]verall, however, children exposed to 
cocaine prenatally appear to have neurological and cognitive deficits.”33 
In contrast, the authors of a systematic review of a collection of studies on 
prenatal cocaine exposure report that “[t]here is little impact of prenatal 
cocaine exposure on children’s scores on nationally normed assessments of 
cognitive development.”34 
Like alcohol and tobacco, cocaine is also associated with addiction, 
engendering a plethora of additional concerns in the regulatory realm. 
 
 29. Grandjean & Landrigan, supra note 28, at 2169–70. 
 30. Laws that treat women differently based on their pregnancy status may be subject to 
constitutional challenge, particularly under the Equal Protection Clause. See, e.g., Pregnancy 
Discrimination Act of 1978, Pub. L. No. 95-555, 92 Stat. 2076 (amending “Title VII of the Civil Rights 
Act of 1964 to prohibit sex discrimination on the basis of pregnancy” in the context of employment). 
For a discussion of equal protection and pregnancy, see, for example, Nora Christie Sandstad, 
Pregnant Women and the Fourteenth Amendment: A Feminist Examination of the Trend to Eliminate 
Women’s Rights During Pregnancy, 26 Law & Ineq. 171, 189–95 (2008). 
 31. See, e.g., Irena Nulman et al., The Effects of Intrauterine Cocaine Exposure on 
Neurodevelopment of Adopted Children: The Toronto Adoption Study, 65 Clinical Pharmacology & 
Therapeutics 138, 138 (1999) (discussing several studies of children’s neurodevelopment following in 
utero cocaine exposure). 
 32. Steven E. Hyman, How Might Cocaine Interfere with Brain Development?, 5 PLoS Med. 857, 
857 (2008). 
 33. Id. 
 34. Deborah A. Frank et al., Growth, Development, and Behavior in Early Childhood Following 
Prenatal Cocaine Exposure: A Systematic Review, 285 JAMA 1613, 1615 (2001). 
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Unlike alcohol and tobacco, criminal provisions ban possession and use 
of cocaine by persons of any age in the United States.35 Because of the 
illegal nature of the drug, much more intensive scrutiny often accompanies 
cocaine use by pregnant women.36 This scrutiny has raised serious social 
justice concerns, some of which are discussed in Part III. 
A second category of research addresses potential environmental 
threats, such as Bisphenol A (“BPA”), which are currently under 
substantial scrutiny and about which debate rages.37 BPA “is a chemical 
that has been used for more than 40 years in the manufacture of many 
hard plastic food containers, such as baby bottles and reusable cups and 
the lining of metal food and beverage cans, including canned liquid infant 
formula. Trace amounts of BPA can be found in some foods packaged in 
these containers.”38 To give some perspective on the debate and the 
evolving approach to BPA, consider the FDA’s website’s informational 
summary concerning BPA: 
BPA (Bisphenol A) is a chemical used in certain food contact materials 
and first approved by FDA in the early 1960s. In recent years, concerns 
have been raised about BPA’s safety. In August 2008, FDA released a 
draft report finding that BPA remains safe in food contact materials. 
On October 31, 2008, a subcommittee of FDA’s science board raised 
questions about whether FDA’s review had adequately considered the 
most recent scientific information available. On January 15, 2010 and 
again on March 30, 2012, the FDA issued an interim update on BPA.39 
In the March 30th update, the FDA indicated that,  
 
 35. See, e.g., 21 U.S.C. § 844 (2010) (“It shall be unlawful for any person knowingly or 
intentionally to possess a controlled substance unless such substance was obtained directly, or 
pursuant to a valid prescription or order . . . .”). 
 36. See, e.g., Dorothy E. Roberts, Punishing Drug Addicts Who Have Babies: Women of Color, 
Equality, and the Right of Privacy, 104 Harv. L. Rev. 1419, 1428–31 (1991) (“Some child protection 
agencies institute neglect proceedings to obtain custody of babies with positive toxicologies based 
solely on these tests. . . . [G]overnment authorities are also removing drug-exposed newborns from 
their mothers immediately after birth pending an investigation of parental fitness. In these 
investigations, positive neonatal toxicologies often raise a strong presumption of parental unfitness, 
which circumvents the inquiry into the mother’s ability to care for her child that is customarily 
necessary to deprive a parent of custody.” (footnotes omitted)). 
 37. See Khadijah Rentas, To Ban or Not to Ban, Bisphenol-A in Food Is OK with FDA, But Not 
with Some Scientists, Columbia Missourian, Jan. 9, 2009, available at http://www. 
columbiamissourian.com/stories/2009/01/09/to-ban-or-not-to-ban/ (presenting the views of a scientist 
who researches BPA and expresses substantial health concerns about human ingestion of BPA). 
 38. Bisphenol A (BPA) Information for Parents, U.S. Dep’t of Health & Hum. Servs., 
http://www.hhs.gov/safety/bpa/ (last visited July 1, 2012). 
 39. Food: Bisphenol A (BPA), U.S. Food & Drug Admin., http://www.fda.gov/food/ 
foodingredientspackaging/ucm166145.htm (last visited July 1, 2012) (footnotes omitted). The FDA 
website also links to a European report: Eur. Food Safety Auth., Statement of EFSA on a Study 
Associating Bisphenol A with Medical Disorders 1 (2008) (“EFSA concluded that this single study 
does not provide sufficient proof for a causal link between exposure to BPA and the health conditions 
mentioned in the study, i.e. heart disease, diabetes and elevated liver-enzyme activities. Therefore, 
EFSA considers that there is no need to revise the TDI as derived by the AFC Panel in 2006.”). 
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[a]t this interim stage, FDA shares the perspective of the National 
Toxicology Program that recent studies provide reason for some 
concern about the potential effects of BPA on the brain, behavior, and 
prostate gland of fetuses, infants and children. FDA also recognizes 
substantial uncertainties with respect to the overall interpretation of 
these studies and their potential implications for human health effects 
of BPA exposure.40 
As these materials indicate, divergent views among scientists within the 
FDA provoked a revisiting of the issue and a changing perspective on 
BPA. Concurrently, the FDA and the HHS have promulgated advice to 
parents for reducing infant exposure to BPA.41 The HHS site now explains 
that “recent studies have reported subtle effects of low doses of BPA in 
laboratory animals. While BPA is not proven to harm children or adults, 
these newer studies have led federal health officials to express some 
concern about the safety of BPA.”42 Investment in new research and 
acknowledgement of the need for this revisiting of the potential hazards 
of BPA represent important modifications to the FDA’s approach to 
BPA.43 
The debate over the potential hazards of BPA has also apparently 
spawned a rethinking of the way scientists conduct studies on BPA in 
academic environments.44 With the recent influx of thirty million dollars 
in funding to study BPA, the FDA apparently has revised protocols for 
conducting these experiments.45 The aim is to produce studies where the 
protocols coincide, and comparing the results thus involves comparing 
apples to apples.46 In the meantime, while the federal approach continues 
to evolve, a number of states are banning BPA use in various products.47 
 
 40. Bisphenol A: Use in Food Contact Application, U.S. Food & Drug. Admin., 
http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm064437.htm (last visited July 1, 2012). 
 41. Id.; Bisphenol A (BPA) Information for Parents, supra note 38 (“It is clear that the 
government and scientists and doctors need more research to better understand the potential human 
health effects of exposure to BPA, especially when it comes to the impact of BPA exposure on young 
children. The Department of Health and Human Services—through its Centers for Disease Control 
and Prevention (CDC), the National Institutes of Health (NIH), and the Food and Drug 
Administration (FDA)—is investing in important new health studies in both animals and humans to 
better determine and evaluate the potential health effects of BPA exposure, including $30 million in 
studies at NIH. We expect to have the results of this scientific research in approximately 18 to 24 
months. While we learn more, the Food and Drug Administration is supporting current efforts by 
industry to stop the manufacture of infant bottles and feeding cups made with BPA from the U.S. 
market. The FDA is also seeking to strengthen its oversight of BPA so the agency can respond 
quickly, if necessary, when more scientific evidence becomes available.”). 
 42. Bisphenol A (BPA) Information for Parents, supra note 38. 
 43. For a discussion of the investment in research, see supra note 41. 
 44. See generally Brendan Borrell, The Big Test for Bisphenol A, 464 Nature 1122 (2010). 
 45. Id. at 1124. 
 46. Id. 
 47. See, e.g., California BPA Ban Signed into Law, Food Safety News, Oct. 6, 2011, http://www. 
foodsafetynews.com/2011/10/california-bpa-ban-signed-by-gov-brown/ (reporting on California’s BPA 
ban, scheduled to become effective in July 2013). 
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Along the spectrum of research on environmental threats, some 
potential threats have yet to trigger regulatory control. Though these 
potential threats may not yet invoke substantial regulatory action, they 
may merit public attention. In May 2011, the American Academy of 
Pediatrics issued a report condemning the lack of access to important 
information about chemicals introduced and currently in use in the 
United States.48 The report criticizes current constraints on the 
Environmental Protection Agency (“EPA”) that prevent the EPA from 
revealing information about potential hazards associated with certain 
chemicals.49 The report explains: 
[C]oncerns about chemicals are permitted to be kept from the public. 
In their notifications to the EPA, chemical companies may declare 
large amounts of information to be “confidential business information.” 
This broad exemption has effectively prevented the EPA from sharing 
information about potentially hazardous chemicals with community 
groups, local and state governments, and foreign governments or 
international organizations.50 
Pregnant women, physicians, and policymakers should be able to 
access information, early research, and a credible evaluation of such 
research even if the research results are not sufficiently persuasive to 
trigger cautionary advisories or condemnation by the government. After 
all, in 2008, the FDA assured the world that BPA was safe in food contact 
materials, despite multiple studies suggesting otherwise.51 Where scientific 
consensus will land in the debate on the potential hazards of BPA remains 
to be seen. But pregnant women and their physicians, among others, 
need more comprehensive and earlier access to emerging information 
about potential hazards. The risk threshold of pregnant women may be 
much lower than the FDA’s. And, as suggested by the methylmercury 
hypothetical above, their actual risk can be much higher than the average 
risk level that may underlie FDA regulation. 
 
 48. Am. Acad. of Pediatrics, Policy Statement—Chemical-Management Policy: Prioritizing 
Children’s Health, 127 Pediatrics 983 (2011). 
 49. Id. at 985. 
 50. Id. 
 51. See, e.g., Oversight on EPA Toxic Chemical Policies: Hearing Before the S. Comm. on Env’t & 
Pub. Works, 110th Cong. (2008) (statement of Dr. Linda C. Giudice, Professor, University of 
California, San Francisco) (“In a series of important studies by Dr. Pat Hunt at Washington State 
University, pregnant mice were exposed to BPA, which resulted in exposure to the developing fetus. 
This exposure to BPA damaged female fetus’s new eggs, known as oocytes. The daughter’s eggs were 
more likely to have chromosomal abnormalities, which increased the likelihood of a granddaughter 
with genetic defects.”); see also Borrell, supra note 44, at 1122–24 (discussing scientists and studies 
raising concern about BPA); Rentas, supra note 37 (writing about a scientist who expresses substantial 
health concerns about human ingestion of BPA). 
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II.  Structural Constraints and Avenues of Regulation 
Regulation entails more than a determination that the environmental 
agent is correlated with or even causes harm. It also depends on at least 
three additional critical factors: (1) regulatory constraints, including the 
“tilt” principle applied to the task before the regulator, with the term 
“tilt” suggesting the lens or perspective through which potentially 
hazardous chemicals are evaluated; (2) translating the science into policy, 
which includes a cost-benefit analysis of any harms against any benefits; 
and (3) the identity and role of the regulator. 
A. Regulatory Constraints and the “Tilt” Principle 
Regulation of potential threats to the prenatal brain depends first on 
the constraints imposed on the regulator.52 Take, for example, the EPA.53 
The EPA possesses regulatory authority over approximately 80,000 
chemicals in U.S. commerce.54 Even advocates for reform of regulatory 
policy acknowledge the U.S. chemical industry’s contributions to 
“economic growth, employment, and improvements in life expectancy, 
health, and living conditions.”55 But with trillions of pounds of chemicals 
manufactured in or imported into the United States each year,56 the need 
for careful regulation of the safety of such chemicals is essential. 
Constraints on such regulation here include the enabling legislation that 
drives and cabins the EPA’s authority. With respect to regulation of 
potentially toxic chemicals, much of its animating authority derives from 
the Toxic Substances Control Act (“TSCA”) enacted by Congress in 
1976.57 Scholars note that, pursuant to TSCA, 
the U.S. EPA has been able, since 1976, to use its formal rule-making 
authority to partially regulate five existing chemicals (or chemical 
classes): polychlorinated biphenyls (PCBs), chlorofluorocarbons, dioxins, 
asbestos, and hexavalent chromium. Of these, an amendment by 
Congress to TSCA required regulation of PCBs, and the U.S. EPA’s 
 
 52. This Article construes the term “regulator” broadly to include not only governmental entities 
but also private entities and the pregnant woman herself. Each of the organizations or persons can 
exert control and potentially regulate aspects of fetal health. 
 53. For an informative discussion of limitations on the EPA’s regulation of environmental 
chemicals, see generally Wilson & Schwarzman, supra note 2. 
 54. Id. at 1203. 
 55. Id. 
 56. Id. 
 57. Toxic Substances Control Act of 1976, 15 U.S.C. §§ 2601–29 (1976); U.S. Gov’t 
Accountability Office, GAO-05-458, Chemical Regulation: Options Exist to Improve EPA’s 
Ability to Assess Health Risks and Manage Its Chemical Review Program 1 (2005) (“TSCA 
addresses those chemicals manufactured, imported, processed, distributed in commerce, used, or 
disposed of in the United States, but excludes certain substances including, among other things, 
pesticides that are regulated under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA); 
and food; food additives; drugs; cosmetics or devices that are regulated under the Federal Food, Drug 
and Cosmetic Act (FFDCA).”). 
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asbestos regulation, promulgated after the agency spent 10 years 
building its case, was overturned in its most significant aspects by the 
5th Circuit Court of Appeals, which concluded that the U.S. EPA had 
failed to meet its burdens of proof under TSCA.58 
Regulation of this type that is limited to these few chemicals or 
chemical classes does not result from research and convincing proof that 
the remaining thousands of chemicals are safe. Rather, a report to 
Congress suggests that it results from the constraints imposed by TSCA on 
the regulator.59 The following excerpt from the Government 
Accountability Office’s report to Congress underscores the constraints 
inherent in TSCA: 
TSCA generally places the burden of obtaining data on existing 
chemicals on EPA, rather than on the companies that produce the 
chemicals. For example, the act requires EPA to demonstrate certain 
health or environmental risks before it can require companies to 
further test their chemicals. As a result, EPA does not routinely assess 
the risks of the roughly 80,000 industrial chemicals in use. Moreover, 
TSCA does not require chemical companies to test the approximately 
700 new chemicals introduced into commerce annually for their toxicity, 
and companies generally do not voluntarily perform such testing. 
Further, the procedures EPA must follow in obtaining test data from 
companies can take years to complete. . . . 
While TSCA authorizes EPA to issue regulations that may, among 
other things, ban existing toxic chemicals or place limits on their 
production or use, the statutory requirements EPA must meet present 
a legal threshold that has proven difficult for EPA and discourages the 
agency from using these authorities. For example, EPA must 
demonstrate “unreasonable risk,” which EPA believes requires it to 
conduct extensive cost-benefit analyses to ban or limit chemical 
production. . . . GAO has previously recommended that Congress 
amend TSCA to reduce the evidentiary burden EPA must meet to 
control toxic substances and continues to believe such change warrants 
consideration.60 
These regulatory constraints illustrate the larger overarching “tilt” 
principle through which TSCA operates. The regulatory tilt in this 
paradigm is sometimes referred to as the “smoking gun principle.”61 This 
tilt suggests that regulatory agencies should permit the target substance’s 
 
 58. Wilson & Schwarzman, supra note 2, at 1205 (citation omitted); see Am. Acad. of Pediatrics, 
supra note 48, at 983. 
 59. See generally U.S. Gov’t Accountability Office, GAO-09-428T, Chemical Regulation: 
Options for Enhancing the Effectiveness of the Toxic Substances Control Act (2009). 
 60. Id. at i (“Since 1976, EPA has issued regulations to control only five existing chemicals 
determined to present an unreasonable risk. Further, its 1989 regulation phasing out most uses of 
asbestos was vacated by a federal appeals court in 1991 because it was not based on ‘substantial 
evidence.’ In contrast, the European Union and a number of other countries have largely banned 
asbestos, a known human carcinogen that can cause lung cancer and other diseases.”). 
 61. Moore, supra note 10, at 7. 
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use unless there has been a showing that the substance is a health hazard.62 
As indicated by the report above, the EPA must demonstrate a specified 
level of risk before it can take action to ban a chemical. This implies that 
the EPA is subject to a smoking gun tilt in regulating under TSCA. A 
second paradigm, generally referred to as the “Precautionary Principle,” 
operates from a very different starting point: “[W]hen an activity raises 
threats of harm to human health or the environment, precautionary 
measures should be taken even if some cause and effect relationships are 
not fully established scientifically. In this context the proponent of an 
activity, rather than the public, should bear the burden of proof.”63 
Adoption of one paradigm versus the other can tilt the result 180 
degrees, with one paradigm permitting introduction of the chemical into 
commerce with little or no testing and the other requiring precautionary 
measures, such as requiring the introducing party to shoulder some 
burden of information production or proof regarding safety. 
Scholars in the field, as well as the Government Accountability 
Office’s report quoted above, have encouraged Congress to adopt a 
more precautionary tilt and to emulate to a greater extent models like 
the European Union model of Registration, Evaluation, Authorization, 
and Restriction of Chemicals (“REACH”).64 According to authorities 
who study regulatory approaches, REACH is structurally distinct from 
TSCA.65 REACH requires that the importers and manufacturers of the 
chemical, rather than the government, supply “basic information on the 
identity and physical properties of [approximately] 30,000 chemicals sold 
in volumes of more than one metric ton per year, per producer.”66 
REACH also contemplates special treatment for “Substances of Very 
High Concern.”67 For these substances, the burden on the introducing 
party for continued use depends “on producers’ demonstrating the safety 
of each intended use, or that in the absence of suitable alternatives, the 
socioeconomic benefits outweigh the health and environmental risks.”68 
 
 62. Id. 
 63. Wingspread Conference on the Precautionary Principle, Sci. & Envtl. Health Network (Jan. 
26, 1998), http://www.sehn.org/wing.html; see Moore, supra note 10, at 8. 
 64. See, e.g., U.S. Gov’t Accountability Office, supra note 59, at 14 (“REACH requires greater 
public disclosure of certain information, such as basic chemical properties. Furthermore, REACH 
places greater restrictions on the kinds of information chemical companies may claim as confidential. 
For example, REACH includes a provision for public access to basic chemical information, including 
brief profiles of hazardous properties and authorized uses. The European Union’s approach to [the] 
public’s access to information combines a variety of ways that the interests of the public’s right to 
know is balanced with the need to keep certain information confidential.”); Megan R. Schwarzman & 
Michael P. Wilson, New Science for Chemicals Policy, 326 Sci. 1065, 1065 (2009). 
 65. Schwarzman & Wilson, supra note 64, at 1065 (citation omitted). 
 66. Id. 
 67. Id. 
 68. Id. 
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REACH appears to incorporate much more of a precautionary tilt than 
does TSCA. 
The tilt principle and other constraints that are often involved in the 
political process that produces federal regulation support the need for 
voices external to the regulating agency on the question of regulation. 
These constraints suggest the need for an organization that can provide 
an independent, comprehensive review across disciplines such as science, 
law, and economics for evaluation and information sharing about risks 
and proposed responses to potential threats to fetal health. 
B. Translating Science for Use in Policy and Law 
Beyond the tilt and general regulatory constraints, there remains the 
challenge of translating science for use in policy and law. Tomes have been 
written on this topic.69 Here, at a minimum, it is worth noting that science 
produces various types of evidence, many of which do not necessarily 
translate directly into policy. How much and what types of evidence are 
enough to warrant intervention? What level of certainty is needed for 
regulatory action? What types of regulatory action are appropriate in the 
face of the evidence? 
For instance, even a comprehensive and unassailable scientific 
result—one based on multiple studies that a particular substance has 
been correlated with specific learning deficits in one percent of 
children—does not immediately dictate the parameters or contents of 
regulatory legislation. Regulatory policy also considers, for example, the 
benefits, if any, of the chemical. Let’s hypothesize that the chemical is 
critical for space travel or deep-sea exploration. Does the legislation ban 
all future manufacturing of the chemical or limit its dissemination? Does 
it govern recall of all the products into which the chemical has already 
been incorporated? Does it govern disposal of those recalled products? 
Regulation here should evaluate and depend upon scientific inquiry, but it 
also embraces considerations beyond research results. Value judgments 
and economic considerations, among others, infuse the regulatory process. 
Moreover, government regulation emerges from a political vortex, with 
different constituencies vying for influence. Making the science count in 
the complex equation that produces regulation is a significant challenge. 
C. The Identity and Role of the Regulator 
Regulation depends not only on the constraints of the animating 
forces behind the regulation and the complexity of translating science into 
 
 69. See, e.g., David L. Faigman et al., Modern Scientific Evidence: The Law and Science of 
Expert Testimony (2011); David L. Faigman et al., Modern Scientific Evidence: Standards, 
Statistics, and Research Methods (2008). 
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policy or law, but also on the identity and role of the regulator. This 
Subpart considers a number of regulators external to the mother. External 
legal regulators assume two primary forms: governmental and non-
governmental actors. 
Many governmental actors play roles in the regulation of 
environmental threats to the fetal brain. In the scholarly literature, one 
often finds them divided into two contingents. First, a substantial 
contingent participates in the direct regulation of the industries that 
manufacture, transport, and produce products associated with the threats, 
particularly potentially toxic chemicals.70 These include agencies such as 
the EPA and the FDA.71 Regulation here might also include federal 
prosecutors pursuing civil or criminal charges against industry violators 
of federal law under, for example, TSCA.72 These and other government 
agencies also participate indirectly in the regulation of industry through 
public education. A second contingent of governmental actors has been 
employing criminal justice vehicles to attempt to regulate maternal 
behavior. Primarily, these are state prosecutors who, under a variety of 
theories, have prosecuted mothers for the transmission of illegal drugs to 
their fetuses or newborn children.73 Pregnant women, perhaps particularly 
poor women, may be even more likely to encounter another set of 
government regulators: those in the realm of dependency and child 
protective services.74 
 
 70. See, e.g., Schwarzman & Wilson, supra note 64, at 1065 (“The U.S. Toxic Substances Control 
Act (TSCA) is the primary mechanism by which the Environmental Protection Agency (EPA) is 
expected to oversee more than 80,000 chemicals.”). 
 71. See, e.g., id. 
 72. For an example of civil enforcement, see Vidiksis v. E.P.A., 612 F.3d 1150 (11th Cir. 2010) 
(upholding a finding of liability and a civil penalty of $97,545 on sixty-nine violations of TSCA section 
409 alleged in the EPA’s administrative complaint against John P. Vidiksis). TSCA also provides for 
criminal enforcement of its provisions: 15 U.S.C. § 2615(b) (2010) (“Any person who knowingly or 
willfully violates any provision of section 2614 or 2689 of this title, shall, in addition to or in lieu of any 
civil penalty which may be imposed under subsection (a) of this section for such violation, be subject, 
upon conviction, to a fine of not more than $25,000 for each day of violation, or to imprisonment for 
not more than one year, or both.”). 
 73. See, e.g., Whitner v. State, 492 S.E. 2d 777 (S.C. 1997) (finding that it was not a violation of 
the petitioner’s constitutional right to privacy to prosecute her for child abuse and endangerment for 
taking cocaine while pregnant); Synopsis of State Case and Statutory Law, 1 Yale J. Health Pol’y L. 
& Ethics 237 (2001) (providing a detailed state-by-state summary of provisions related to statutes and 
criminal cases addressing pregnant women and the prenatal use of alcohol and illegal drugs); Ada 
Calhoun, The Criminalization of Bad Mothers, N.Y. Times, Apr. 25, 2012, at MM30 (focusing on the 
prosecution of mothers for their ingestion of illegal drugs during pregnancy). 
 74. Cf. Ian Vandewalker, Taking the Baby Before It’s Born: Termination of the Parental Rights of 
Women Who Use Illegal Drugs While Pregnant, 32 N.Y.U. Rev. L. & Soc. Change 423, 425 (2008) 
(“Sixteen states have statutes providing that the use of illicit or controlled substances during 
pregnancy is child abuse. Other states allow prenatal drug use to be considered in determinations of 
child status as abused, neglected, dependent, in need of assistance, or the like, even without a statutory 
mandate. While only one state, Illinois, has a statute explicitly providing for termination due to 
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Apart from government actors, private parties and non-
governmental organizations also serve as regulators. In addition to roles 
as educators and enablers or disputants of formal governmental policy, 
these actors regulate the womb through private civil law suits, in 
particular class action suits.75 Consumers as private actors also regulate 
the extent and frequency of some potential environmental threats 
through their wallets, by buying or declining to purchase products that 
contain potentially toxic chemicals. For instance, the movement over the 
past few years toward retail stocking of BPA-free reusable plastic bottles 
seems to have been driven by consumer preference, rather than formal 
government regulation.76 This, of course, is an indirect, but ultimately 
highly persuasive, form of regulation for certain types of products. 
Consumer regulation of this form may result in the removal of a particular 
suspected toxic chemical from products, but it does not necessarily govern 
the safety of any substituted or replacement chemicals. 
The media, of course, may also play a significant role in regulating 
potential threats to the fetal brain by bringing research to light and 
unearthing hidden biases and economic or political ties.77 Other private 
actors, particularly health care providers through their advice to 
prospective parents and pregnant women, regulate potential threats to 
fetal health.78 A 2011 report from the American Academy of 
Pediatricians encourages pediatricians to 
familiarize themselves with the information about chemicals in the 
environment and their effects on child health. Many chemicals are 
reviewed in the American Academy of Pediatrics manual Pediatric 
Environmental Health. . . . 
Pediatricians should learn about the resources contained in the 
Environmental Health and Toxicology pages of the National Library of 
 
prenatal drug use, child welfare laws in all states may be used by judges or social services agencies to 
permanently remove children from mothers who used drugs while pregnant.” (footnotes omitted)). 
 75. The morning sickness drug, Bendectin, provides an example. The drug was pulled from the 
market in the wake of lawsuits claiming it caused birth defects. See Gina Kolata, Controversial Drug 
Makes a Comeback, N.Y. Times, Sept. 26, 2000, at F1. Diclectin, apparently made with the same 
ingredients as Bendectin, see id., is now available in Canada to treat morning sickness. See Diclectin, 
Duchesnay Inc., http://www.diclectin.com/ (last visited July 1, 2012). 
 76. See, e.g., Editorial on Banning Bisphenol A from Food Containers: FDA Should Do Its Job, 
S.F. Chron., Mar. 25, 2012, at E10 (noting that a number of retailers already often decline to stock 
products with BPA and relating that change to consumer preferences and industry approaches). 
 77. Some media reports have also been criticized for raising potentially unnecessary alarm in 
their reporting about possible environmental toxicant harm to fetal development. See, e.g., Rebecca 
Goldin, Media Claims Phthalates (Might) Cause Genital Defects, STATS (May 27, 2005), http:// 
stats.org/stories/2005/media_claims_phthala_may27_05.htm (criticizing a media report about phthalate 
study). 
 78. Efforts to bring current research about environmental risks to reproductive health to clinical 
health care providers are a focus, for example, of the UCSF Program on Reproductive Health and the 
Environment. Expanding Clinical Practice, Program on Reprod. Health & the Env’t, 
http://coe.ucsf.edu/prhe/clinical/index.html (last visited July 1, 2012). 
Bloch_26 (S. Alessi) (Do Not Delete) 8/14/2012 2:20 PM 
1590 HASTINGS LAW JOURNAL [Vol. 63:1571 
 
Medicine Web site. Those portions that will be of most use in 
counseling families include Lact-Med (a peer reviewed and fully 
referenced database of drugs to which breastfeeding mothers could be 
exposed) and the Household Products Database (which links >8000 
consumer brands to chemicals they may contain on the basis of 
Material Safety Data Sheets provided by the manufacturers).79 
These recommendations also reference several useful online resources. 
Would not their valuable recommendations serve more audiences if 
prepared as part of a single online resource and presented in ways 
accessible not only to physicians but also to expectant parents, 
breastfeeding mothers, and non-physician policymakers? 
Most important, all of the above actors need current, well-digested, 
evaluated, and accessible information about environmental threats to 
fetal development so that they can make informed decisions. Pregnant 
women need information in this form as they are the first-line 
decisionmakers, regulators, and protectors of themselves and their fetuses. 
Busy front-line physicians need an independent gatherer and interpreter of 
research on fetal development that is not subject to the influence of special 
interest groups in the political process. Actors beyond pregnant women 
and their physicians who interact with and attempt to regulate maternal 
behavior need accurate understandings of research on fetal development. 
If, for example, experience and research suggest that prosecuting 
mothers for transmission of illegal drugs to their fetuses translates into 
fewer mothers seeking prenatal care,80 and if the research further 
indicates worse outcomes for the fetus without prenatal care81 even if the 
 
 79. Am. Acad. of Pediatrics, supra note 48, at 988–89 nn.1–2 (citations omitted). 
 80. See, e.g., Emily Figdor & Lisa Kaeser, Concerns Mount over Punitive Approaches to Substance 
Abuse Among Pregnant Women, Guttmacher Rep. Pub. Pol’y., Oct. 1998, at 3, 4 (“[A]ccording to the 
South Carolina Association of Alcoholism and Drug Abuse Counselors, drug treatment programs in 
South Carolina experienced as much as an 80% decline in the admission of pregnant women in the 
year following the state supreme court’s highly publicized decision [of Whitner v. State, 492 S.E. 2d 777 
(S.C. 1997)].”). Whitner upheld a woman’s guilty plea “to criminal child neglect for causing her baby to 
be born with cocaine metabolites in its system by reason of Whitner’s ingestion of crack cocaine during 
the third trimester of her pregnancy.” 492 S.E. 2d at 778–79 (citation omitted); see also Krista Stone-
Manista, Protecting Pregnant Women: A Guide to Successfully Challenging Criminal Child Abuse 
Prosecutions of Pregnant Drug Addicts, 99 J. Crim. L. & Criminology 823, 836 (2009) (“Moreover, 
public health officials generally discourage these prosecutions, believing that pregnant women tend to 
react to the threat of prosecution not by terminating their drug use, but by avoiding prenatal care.”). 
 81. Frank et al., supra note 34, at 1621 (“[F]ear of prosecution may discourage pregnant and 
parenting women from seeking prenatal care and drug treatment, which have been shown to optimize 
infant outcome.” (citations omitted)); Derk B.K. VanRaalte IV, Punitive Policies: Constitutional 
Hazards of Non-Consensual Testing of Women for Prenatal Drug Use, 5 Health Matrix 443, 457 
(1995) (“The [Association of Maternal and Child Health] Policy Statement on punitive measures 
concluded that ‘[c]riminal prosecution of chemically dependent women will have the overall result of 
deterring such women from seeking both prenatal care and chemical dependency treatment, thereby 
increasing, rather than preventing, harm to children and society as a whole.’ . . . Given that evidence 
suggests that prenatal care may be more important than maternal drug use in determining fetal health, 
punitive approaches appear to do more harm than good.” (footnotes and citation omitted)). 
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mother continues to ingest illegal drugs during her pregnancy, then that 
is research governmental actors should have access to and consider. 
Research about the relative benefits or detriments of criminal justice 
interventions, such as drug courts82 or incarceration during pregnancy,83 
also fits within the province of an entity gathering research about 
potential environmental threats to fetal health. Because this type of 
research is relevant to audiences concerned with fetal development and 
environmental hazards, a think tank clearinghouse should collect and 
interpret research on social justice issues involving fetal health. For 
example, what does the empirical research suggest about disparate impacts 
of regulation on poor women and women of color?84 How can that 
research better inform fetal health law and policy? Instead of combing 
through dozens and perhaps hundreds of websites, consumers, pregnant 
women, physicians, policymakers, other regulators, and the public more 
generally could locate carefully evaluated and accessibly presented 
research and implementation implications about fetal health on the 
website of one independent think tank. 
III.  Mothers’ Self-Regulation 
Challenges to a mother’s self-regulation abound. The hypothetical 
mother’s experience described in the Introduction illustrates one aspect 
of the daunting challenge to self-regulation—the complexities of when 
and where to look for reliable information. A related challenge involves 
the dearth of accessible and comprehensible information about prenatal 
threats. For instance, even if one locates an important scientific journal 
article on the topic in question, one often needs a subscription or to pay a 
fee to read the full article.85 And even if the searcher achieves physical 
 
 82. See, e.g., Mishka Terplan et al., “Compassionate Coercion”: Factors Associated with Court-
Mandated Drug and Alcohol Treatment in Pregnancy 1994–2005, 4 J. Addict. Med. 147 (2010) 
(describing trends in criminal justice referrals of pregnant women for treatment). 
 83. See, e.g., Jennifer G. Clarke & Eli Y. Adashi, Perinatal Care for Incarcerated Patients: A 25-Year-
Old Woman Pregnant in Jail, 305 JAMA 923, 926 (2011) (“A systematic review of pregnancy outcomes 
for incarcerated women (7 of 10 U.S. studies) reveals that when compared with similarly disadvantaged 
populations, maternal and fetal outcomes improve with increasing lengths of incarceration. One study 
observed that on average, for each day spent in prison during pregnancy, infant birth weight was 1.49 g 
greater than among infants born to women incarcerated at times other than during their 
pregnancies. . . . These studies do not imply that prisons constitute the optimal environment for pregnant 
women; rather, the women in question have a poor preincarceration environment, often characterized by 
poverty, drugs, chaos, and danger, as well as inadequate nutrition and lack of safe shelter.” (footnotes 
omitted)). 
 84. See, e.g., Khiara M. Bridges, Reproducing Race: An Ethnography of Pregnancy as a Site 
of Racialization (2011); see generally Khiara M. Bridges, Poor Women and the Protective State, 63 
Hastings L.J. 1619 (2012); Roberts, supra note 36. 
 85. For example, in researching Mishka Terplan and Tricia Wright’s article, The Effects of Cocaine 
and Amphetamine Use During Pregnancy on the Newborn: Myth Versus Reality, 30 J. Addictive 
Diseases 1 (2010), co-authored by one of the panelists at the Symposium, I was unable to access the full 
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access, specialized knowledge may be necessary for genuine accessibility. 
In addition, respected scientists who publish their research results in 
journal articles may arrive at conflicting conclusions about a topic. 
At the same time that inaccessibility limits the availability of some 
types of important information, such as scientific research results, there 
exists a plethora of information available on the Internet about fetal 
health. While I invented the hypothetical mother confronting the issue of 
fish consumption during pregnancy in this Article’s introduction, Dr. 
Gideon Koren’s empirical research described in his article in this 
Symposium issue documents the confusion of real women in the face of 
conflicting and often overwhelming information about methylmercury 
and fish consumption during pregnancy. His organization, Motherisk, 
conducted research with women who had contacted Motherisk regarding 
their concerns about “the reproductive safety of consuming fish during 
pregnancy.”86 Dr. Koren notes that 
[h]alf of the participants stated that they initially became aware of the 
issue of mercury in fish through electronic and printed media . . . and 
almost all had called for clarity after what they had heard from these 
sources. Those who had searched the Internet found a vast amount of 
information, some of which was described by them as dramatic and 
overstated . . . . After reading the controversial and varied opinions, 
they wanted clarity.87  
Where does one look? To whom does one turn when sources conflict? 
How does one interpret complex scientific research and determine what it 
means? With the Internet information overload, trusted guides and 
interpreters become crucial.88  
Self-regulation for some pregnant women means navigating the 
terrible challenges of pregnancy amidst poverty.89 For some, it means 
 
text without having login privileges. See Taylor & Francis Online, http://www.tandfonline.com/doi/pdf/ 
10.1080/10550887.2011.532048 (last visited July 1, 2012). I was informed, “Sorry, you do not have access 
to this article” and given options as to how to access the article. Id. The site suggested I could 
“[r]ecommend to [my] librarian that [my] institution purchase access to this publication.” Id. Or, I 
could pay $36 for access to the article or pay $269 for permanent access to the full issue. Id. 
 86. Koren et al., supra note 4, at 1608.  
 87. Id. at 1610–11. 
 88. Fortunately for the women in Dr. Koren’s study who contacted Motherisk, they found a 
respected interpreter on the studies and information on methylmercury. Such a respected interpreter 
should be available to everyone on topics of importance to fetal health. The umbrella entity proposed 
here is designed to serve as that interpreter on a broad range of issues related to environmental risks to 
fetal health. 
 89. Poverty also creates barriers to Internet access, constructing an additional hurdle for self-
regulation for these women. More, but not yet enough, free Internet opportunities are developing. Today, 
public libraries are often the free source of computers with Internet access. Info. Inst., Fla. St. Univ., 
Internet Connectivity in U.S. Public Libraries: U.S. Public Libraries Provide Critical Access to 
Internet Services 1 (2008) (“Nearly all of America’s 16,543 public library buildings offer free public 
access to computers, to the Internet and to trained staff equipped to help library users gain technology 
skills and find the information they need for school, work and more. This public service provides a critical 
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confronting the enslavement of addiction. For others, it means facing the 
escalation of domestic violence that sometimes accompanies pregnancy.90 
Research relevant to these issues and others that bears on environmental 
risks to fetal health, as well as information on resources available for 
addressing them, should be within the purview of a single entity. 
IV.  Creating the Think Tank Clearinghouse 
A. Need 
The need for a think tank clearinghouse derives from a variety of 
circumstances. The need arises both from the inaccessibility of some types 
of research information about fetal health and from the simultaneous 
inundation of other information about fetal health. As noted above, some 
research, often important empirical studies, can be highly challenging to 
locate and even then access must sometimes be purchased.91 As authors 
at the Johns Hopkins Women’s and Children’s Health Policy Center 
explain: “A critical challenge for both consumers and clinicians is the 
inaccessible and dispersed nature of information about environmental 
toxicants and pregnancy available online.”92 They opine that “[f]ederal 
agencies, professional organization[s], and other groups have created 
websites and briefs on environmental toxicants. However, these sites are 
often highly technical and detailed, difficult to navigate, and include a 
very broad array of substances. Most important, the information is not 
organized with reproductive health concerns in mind.”93 
 
source for millions of Americans as nearly three-quarters of public libraries (72.5 percent) reported in a 
2007–2008 study that they are the ONLY provider of free access to the Internet in their community.”). 
For a discussion of the intersection of pregnancy, poor women, and state regulation in the context of 
potentially toxic chemicals and social justice, see generally Bridges, supra note 84.  
 90. See, e.g., Jay G. Silverman et al., Intimate Partner Victimization Prior to and During 
Pregnancy Among Women Residing in 26 States: Associations with Maternal and Neonatal Health, 
195 Am. J. Obstetrics & Gynecology 140, 140 (2006) (“Women experiencing intimate partner 
violence both prior to and during pregnancy are at risk for multiple poor maternal and infant health 
outcomes, suggesting prenatal risks to children from mothers’ abusive partners.”); Deborah 
Tuerkheimer, Conceptualizing Violence Against Pregnant Women, 81 Ind. L.J. 667, 667 (2006) 
(“Victims of domestic violence often describe a history of battering that begins, or escalates, during 
pregnancy. . . . It becomes obvious to anyone who works with pregnant victims of domestic violence 
that battering during pregnancy is a problem of immense proportions.”). 
 91. Abstracts are commonly available without subscription or fee, but accessing the full article often 
requires subscription or payment. See, e.g., Sheela Sathayanarayana et al., Environmental Exposures: 
How to Counsel Preconception and Prenatal Rights in the Clinical Setting, Am. J. Obstetrics & 
Gynecology, http://www.ajog.org/article/S0002-9378%2812%2900151-2/abstract (last visited July 1, 
2012) (providing a free abstract, but requiring login privileges or paying a purchase price of $30 for 
access to the full article). 
 92. Harrison et al., supra note 19, at 4. 
 93. Id. Some websites that currently address environmental toxicants are, however, generally 
more acessible and do focus on reproductive health. See, e.g., March of Dimes, 
http://www.marchofdimes.com/ (last visited July 1, 2012). 
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These challenges of accessibility suggest the value of an entity that 
would access and evaluate this research and that would translate the 
results of its evaluation into accessible content.94 In contrast to the dearth 
and inaccessibility of some types of data, the sheer quantity of information 
available on the Internet about fetal health is overwhelming. One search 
engine claimed to find about 42,300,000 results for a search on “fetal 
health.”95 Sifting through such an avalanche of information can be 
daunting. This abundance of information as well as the need to parse and 
evaluate that information reinforces the need for an interpretive, 
evaluative entity. 
The need for the Clearinghouse also stems from a desire to create an 
evidence-based, independent evaluator whose charge focuses broadly on 
environmental risks to fetal health. In commenting specifically about 
TSCA, the American Academy of Pediatrics notes that “TSCA has 
created a non-evidence-based system for chemical management.”96 A think 
tank clearinghouse would rely on an evidence-based system for evaluation 
of research. 
In some ways, one of the strongest arguments for an umbrella entity 
is the ability to look more holistically at hazardous chemicals and related 
fetal health concerns. As Professor Colleen Moore, an authority in the 
realm of environmental toxicants and their effects on the development of 
children, explains: “We know very little about how different toxic 
exposures combine—lead plus mercury plus PCBs, plus pesticides, and 
so on.”97 Similarly, the empirical study quoted earlier indicated that the 
interaction and effect of the 287 pollutants and synthetic chemicals found 
in the umbilical cord blood of newborns have never been studied as a 
collected set of chemicals.98 Work on assessing exposure has begun. For 
instance, a study reported in 2011 investigated “biomonitoring data for 
pregnant women from [the National Health and Nutritional Examination 
Survey] to characterize exposure to individual and multiple chemicals 
and their metabolites in pregnant women.”99 Research documenting 
exposure is an important step and arguably a prerequisite to assessing 
impact. An umbrella entity could aid in investigating such interactions by 
identifying new and continuing unmet research needs (and perhaps 
funding sources). Similarly, such an entity could gather and evaluate 
 
 94. A number of existing governmental and non-governmental organizations do access and 
translate research about various environmental risks. See, e.g., infra notes 100–119 and accompanying 
text. 
 95. The search was run on Google.com on February 26, 2012. 
 96. Am. Acad. of Pediatrics, supra note 48, at 985. 
 97. Moore, supra note 10, at 64. 
 98. Houlihan et al., supra note 15, at 13–14. 
 99. Tracey J. Woodruff et al., Environmental Chemicals in Pregnant Women in the United States: 
NHANES 2003–2004, 119 Envtl. Health Persp. 878, 878 (2011). 
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studies that look at collective effects and at the timing of exposure or the 
windows of susceptibility during pregnancy.100 The ability to access all 
these studies in one place could foster meta-analyses that could combine 
information from many sources. An umbrella entity might enable 
researchers and policy makers to see the forest and the trees, so to speak, 
in ways not previously possible.101 
Such an entity, with its focus on fetal health but also with a broad 
mandate to look at research beyond potential chemical toxicity and into 
social justice and other fetal, environmental health related research, 
could provide a resource for a wide variety of policymakers and 
regulators. It might also enable policymakers and regulators to 
understand the relationship among disciplines in ways not previously 
emphasized. An enhanced understanding of the impact of maternal 
incarceration and drug courts on fetal health, and of the social justice 
demographics of the interaction of pregnant women with child protective 
services and the criminal justice system, for example, could enable a 
broader contingent of actors to make better informed choices about 
programs and options that promote fetal health. The Clearinghouse 
could provide that understanding and those perspectives. 
B. Design and Composition 
The Clearinghouse would need content independence from 
government regulation. It would need independence from industry. It 
would need a confirmed and consistent funding source, which is perhaps 
the greatest challenge. One might imagine funding from private 
foundations, for example, or from the National Institutes of Health 
supplying at least a portion of the necessary financial support. Some 
existing partial analogues for such an entity may already exist. Some 
 
 100. Work on windows of particular susceptibility is underway. See, e.g., Targeted Research, Program 
on Reproductive Health & Env’t, http://prhe.ucsf.edu/prhe/research/index.html (last visited July 1, 2012).  
 101. There has been enhanced recent attention to the importance of cumulative impacts. The 
California EPA’s Office of Environmental Health Hazard Assessment created a work group devoted 
to studying cumulative impacts, the Cumulative Impacts and Precautionary Approaches work group, 
which published a report in December 2010. See Linda S. Adams & Joan E. Denton, Cal. Envtl. 
Prot. Agency, Cumulative Impacts: Building a Scientific Foundation iii (2010) (“This report 
presents the first step in developing a screening methodology to evaluate the cumulative impacts of 
multiple sources of pollution in specific communities or geographic areas.”). In addition, a recently 
established website called the Cumulative Impacts Project focuses on the cumulative effects of 
environmental chemical threats to human health. See Cumulative Impacts Project, 
http://cumulativeimpacts.org/ (last visited July 1, 2012). For additional information about cumulative 
impacts and the new cumulative impacts website, see Nancy Myers, The Networker: A New Cumulative 
Impacts Website, 16 Sci. & Envtl. Health Network 4, http://www.sehn.org/Volume_16-4.html (last 
visited July 1, 2012). 
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features of organizations like the March of Dimes,102 or academic institutes 
or programs that evaluate reproductive health research, such as the 
University of California at San Francisco’s Program on Reproductive 
Health,103 might help inform the design of the Clearinghouse. The design, 
composition, and operation of such an entity would also benefit from 
research about the approaches of any similar entities internationally, 
perhaps one like the Motherisk program in Canada.104 I welcome the 
insights of others more knowledgeable about the creation of such entities 
for further proposals on the specifics of the design and composition of 
the Clearinghouse. 
C. Evaluators in Related Domains 
Evidence-based independent evaluators currently exist in relevant 
domains.105 For example, there are a variety of evaluators that focus on 
environmental hazards and health. The University of California Center 
for Occupational and Environmental Health and its sister centers, for 
instance, arose from legislation passed in 1978 establishing these entities 
to “serve government, industry, schools, health professionals, and the 
general public through programs and partnerships designed to deepen 
understanding of occupational and environmental hazards and to prevent 
disease, fatalities, and injuries.”106 The centers focus on environmental 
health, but their charge includes substantial realms outside fetal 
development. Cochrane Reviews offers independent evaluations and 
describes its work as “systematic reviews of primary research in human 
health care and health policy.”107 It provides reviews of environmental 
hazards and fetal development but aims to address human health policy 
throughout the human lifespan. Another organization that researches the 
impact of environmental chemicals on health is the Silent Spring Institute. 
It focuses on links between environmental chemicals and women’s health, 
particularly breast cancer, rather than on fetal development per se.108 
 
 102. March of Dimes, supra note 93 (providing information about fetal health to the general 
public, including pregnant women and medical professionals, as well as funding research about fetal 
health). 
 103. Targeted Research, supra note 100. 
 104. Motherisk News: Oh Baby! . . . Motherisk Turns 25!, Motherisk, http://www.motherisk.org/ 
prof/commonDetail.jsp?content_id=932 (last visited July 1, 2012). 
 105. See supra and infra notes 100–119 and accompanying text. 
 106. COEH at a Glance, Univ. of Cal. Ctr. for Occupational & Envtl. Health, 
http://coeh.berkeley.edu/about/default.htm (last visited July 1, 2012). 
 107. Cochrane Reviews, Cochrane Collaboration, http://www.cochrane.org/cochrane-reviews 
(last visited July 1, 2012). 
 108. About Us, Silent Spring Inst., http://www.silentspring.org/about-us (last visited July 1, 2012) 
(“We partner with physicians, public health and community advocates and other scientists to identify 
and break the links between environmental chemicals and women’s health, especially breast cancer.”). 
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Other evaluators do focus substantially on environmental threats to 
fetal health, or more accurately, maternal-fetal health. In Canada, for 
example, the Motherisk program at the Hospital for Sick Kids describes 
its program as the “pre-eminent international centre for the study of the 
safety or risk of medications used during pregnancy and breastfeeding. 
Motherisk provides information and guidance to pregnant or 
breastfeeding women and health-care professionals regarding risks to the 
fetus or infant from exposure to drugs, chemicals, diseases, radiation and 
environmental agents.”109 The program both conducts its own research 
and evaluates existing research.110 Motherisk also conducts some social 
justice research,111 although that does not appear to be the focus of the 
program. Motherisk provides a related analogue to the proposed 
Clearinghouse, except that Motherisk, an organization based in Canada, 
does not focus on the evaluation of U.S. law and policy. Further, 
Motherisk provides extensive direct services to expectant mothers as 
patients and is also a primary research facility. The Clearinghouse would 
not provide in-person direct patient services, although it might provide, 
depending on staffing, an e-mail or phone interpretive service to explain, 
apply, or clarify its online materials. The Clearinghouse also would not 
serve as a center for conducting front line empirical research. 
Organizations in the United States also direct their research and 
services toward the intersection of environmental risks and maternal-
fetal health. First, for example, like Motherisk, the University of 
California, San Francisco’s Program on Reproductive Health and the 
Environment (“PRHE”) offers another analogue to the Clearinghouse. 
Its mission is to “create a healthier environment for human reproduction 
and development through advancing scientific inquiry, clinical care and 
health policies that prevent exposures to harmful chemicals in our 
environment.”112 PRHE both conducts and evaluates research on 
potential environmental threats to reproductive health.113 To establish 
scientifically based policy proposals and share information, PRHE 
synthesizes research results and develops and advances policy solutions 
 
 109. Motherisk, supra note 104. 
 110. Id. 
 111. Motherisk News: New Research Questions Automatic Removal of Children Living in Grow 
Ops, Motherisk, http://www.motherisk.org/prof/commonDetail.jsp?content_id=945 (last visited July 1, 
2012) (studying children in homes where marijuana was being grown and concluding that automatic 
removal may not be warranted and that removal should be based on a case-by-case evaluation of the 
situation). Although much of the information available on the Motherisk website is of interest 
internationally, the site limits its intended audience with the following disclaimer: “This is a Canadian 
website and its content is intended for Canadian residents only.” Disclaimer, Motherisk, 
http://www.motherisk.org/prof/disclaimer.jsp (last visited July 1, 2012). 
 112. Targeted Research, supra note 100. 
 113. Id. 
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on reproductive health and the environment, including fetal health.114 
While PHRE’s important work offers a useful model for informing the 
creation of the Clearinghouse, it differs from the proposed entity in several 
ways. PRHE’s focus on reproductive health includes health issues beyond 
environmental threats to fetal development. PRHE also conducts primary 
research as part of its research mission, and its evaluation of research does 
not appear to emphasize research in the social justice sphere.  
Second, the Organization of Teratology Information Specialists 
(“OTIS”) also represents an important example analogue and service. 
OTIS “is a non-profit organization made up of individual services (TIS) 
throughout North America. . . . dedicated to providing accurate 
evidence-based, clinical information to patients and health care 
professionals about exposures during pregnancy and lactation.”115 
Patients and health care providers can read online fact sheets and call, 
without fee, to consult with a specialist about environmental exposures 
and their likely effect on a pregnancy.116 OTIS is a direct service and 
research organization focused on original research and supplying 
information to patients and their health care providers. Unlike the 
Clearinghouse, OTIS’s mission does not appear to target applying its 
research to evaluating legislation and U.S. policy generally. Nor does it 
appear that OTIS focuses on social and criminal justice research.  
In another domain related to the proposed scope of the 
Clearinghouse, the Campbell Collaboration reviews research in the 
realms of criminal justice, education, and social welfare.117 Some of this 
research, including articles evaluating drug courts, may be relevant to 
fetal development and environmental toxicants.118 But this organization 
does not focus primarily on either fetal development or environmental 
toxicants. 
All of the organizations described in this Section are entities whose 
approaches may represent analogues related to the mission of the 
proposed Clearinghouse, but the goals of these organizations generally 
include aims outside or different from the mission of the Clearinghouse.119 
 
 114. Advancing Science-Based Policy Solutions, Program on Reprod. Health & Env’t, 
http://prhe.ucsf.edu/prhe/policy/index.html (last visited July 1, 2012). 
 115. Otis Pregnancy, http://www.otispregnancy.org/ (last visited July 1, 2012). . 
 116. Id. 
 117. About Us, Campbell Collaboration, http://www.campbellcollaboration.org/about_us/ 
index.php (last visited July 1, 2012) (“The Campbell Collaboration (C2) helps people make well-
informed decisions by preparing, maintaining and disseminating systematic reviews in education, 
crime and justice, and social welfare . . . . The Campbell Collaboration is an international research 
network that produces systematic reviews of the effects of social interventions.”). 
 118. An example of the research reviewed, this one on drug courts, can be found at Crime and 
Justice Reviews, The Campbell Collaboration, http://www.campbellcollaboration.org/ 
reviews_crime_justice/index.php (last visited July 1, 2012). 
 119. Additional existing related resources include: Health Assessment and Translation (Formerly 
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D. Critiques 
The existence of a range of entities, such as those described above, 
which conduct or review research in relevant domains, raises the 
question of whether the proposed Clearinghouse would be superfluous. 
Based upon research conducted thus far, none of the existing entities 
shares the specific charge that would vitalize the Clearinghouse.120 What I 
 
CERHR), Nat’l Toxicology Program, U.S. Dep’t of Health & Hum. Servs., 
http://ntp.niehs.nih.gov?objectid=497BF6E6-D00C-C4E6-423E8917D64B6A20(last visited July 1, 2012) 
(“The NTP and the National Institute of Environmental Health Sciences established the NTP Office of 
Health Assessment and Translation (OHAT) to serve as an environmental health resource to the public 
and to regulatory and health agencies. This office conducts evaluations to assess the evidence that 
environmental chemicals, physical substances, or mixtures (collectively referred to as ‘substances’) cause 
adverse health effects and provides opinions on whether these substances may be of concern given what is 
known about current human exposure levels. Assessments of potential adverse effects of environmental 
substances on reproduction or development carried out by the Center for the Evaluation of Risks to 
Human Reproduction from 1998–2010, will now be carried out by OHAT.” The Center for the 
Evaluation of Risks to Human Reproduction maintained a core committee of representatives with 
scientific expertise from various government agencies. Its aim, during its first five years, was to evaluate 
two to three chemicals per year. Gloria D. Jankhe et al., Center for the Evaluation of Risks to Human 
Reproduction—The First Five Years, 74 Birth Defects Res. 1, 2, 7 (2005)); March of Dimes, supra note 
93 (providing information about fetal health to the general public, including pregnant women and medical 
professionals, and funding research about fetal health); National Guideline Clearinghouse, U.S. Dep’t of 
Health & Hum. Servs., http://www.guideline.gov/search/search.aspx?term=prenatal+health (last visited 
July 1, 2012) (NGC “is a public resource for evidence-based clinical practice guidelines” that reviews 
research and offers guidelines on health-related topics, including fetal health); PubMed Help, Nat’l Ctr. 
for Biotechnology Info. (last visited July 1, 2012), http://www.ncbi.nlm.nih.gov/books/NBK3827/ 
#pubmedhelp (“PubMed comprises over 21 million citations for biomedical literature from MEDLINE, 
life science journals, and online books. PubMed citations and abstracts include the fields of biomedicine 
and health, covering portions of the life sciences, behavioral sciences, chemical sciences, and 
bioengineering. PubMed also provides access to additional relevant web sites and links to the other NCBI 
molecular biology resources. PubMed is a free resource that is developed and maintained by the National 
Center for Biotechnology Information (NCBI), at the U.S. National Library of Medicine (NLM), located 
at the National Institutes of Health (NIH).”); U.S. Preventive Servs. Task Force, 
http://www.uspreventiveservicestaskforce.org (last visited July 1, 2012) (“The USPSTF is an independent 
panel of non-Federal experts in prevention and evidence-based medicine and is composed of primary 
care providers (such as internists, pediatricians, family physicians, gynecologists/obstetricians, nurses, and 
health behavior specialists). The USPSTF conducts scientific evidence reviews of a broad range of clinical 
preventive health care services (such as screening, counseling, and preventive medications) and develops 
recommendations for primary care clinicians and health systems. These recommendations are published 
in the form of ‘Recommendation Statements.’”). In addition, Search Medica is a general database for 
medical professionals and provides a search feature. See Search Medica, http://goto.searchmedica.com/ 
search.html (last visited July 1, 2012). Additional resources are summarized in Grason & Misra, Summary 
Tables, supra note 19. There has also been a substantial influx of federal government support for various 
studies and environmental health research centers. See generally Michael Szpir, New Thinking on 
Neurodevelopment, 114 Envtl. Health Persp. A100 (2006) (describing studies on various confirmed and 
suspected environmental toxicants and the relatively recent government funding of new studies and 
centers). 
 120. The goal of the Clearinghouse is to serve as the “go to” resource for everyone from women 
contemplating pregnancy to primary-care physicians to policy makers about environmental threats to 
fetal development. If an entity like the Clearinghouse does somehow exist out there and my research 
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am proposing is both broader and more focused than what is currently 
available. The charge of the Clearinghouse would be to evaluate a wide 
range of research and policy related to fetal health, including research on 
environmental toxicity and nutrition, as well as research on existing and 
proposed criminal justice and social justice policy implications related to 
environmental threats. Its charge would include gathering and evaluating 
data and research from a broad swath of sources about fetal health and 
environmental risks and interpreting and presenting that research in 
multiple formats accessible and responsive to the information needs of 
various audiences.121 The entity would also evaluate existing U.S. policies 
and legislation in light of the evolving research on fetal health. 
But the Clearinghouse would not seek to furnish in-person direct 
clinical services to individual patients, nor would it serve as a front line 
empirical research facility conducting its own original research.122 In-
person patient care and conducting original research are, of course, 
extraordinarily valuable roles. But those are roles outside the 
Clearinghouse’s role as an interpreter. Each of those roles requires 
different funding and focus. 
The creation of such a Clearinghouse should not, of course, operate 
to silence other voices engaging in, contributing to, and evaluating the 
research and policy decision making in this field. To the contrary, many 
individuals and organizations, like those discussed in this Part IV, 
currently serve as valuable checks on and influential voices in the 
discussion. Their voices will continue to serve critical roles both 
independently, as they do now, and by informing the work of the 
Clearinghouse. The goal is to create a synergistic relationship among the 
Clearinghouse, researchers, regulators, and others to yield reductions in 
environmental risks to fetal development. 
In addition to the question of the need for the Clearinghouse, 
another potential critique is that umbrella entities that gather health 
information may raise “Big Brother” types of concerns.123 Here, the 
worry would be that enormous amounts of data are collected in one 
repository and that such a database could be mined in intrusive and 
inappropriate ways. The Clearinghouse’s charge does not, however, 
 
has failed to uncover it, this suggests that it is not fulfilling the mission that the Clearinghouse aims to 
fulfill. 
 121. Motherisk, for example, offers one clickable icon for providing information to pregnant and 
lactating women and a separate icon for health care professionals. See Motherisk, supra note 104. 
 122. One might distinguish conducting original empirical research from engaging in meta-analyses 
of the research of other scientists. 
 123. For a discussion of some concerns potentially raised by databases containing personal 
information, see, for example, Emily Stehr, Next Generation Identification—Not a DNA Database, but 
Just as Problematic, Biopolitical Times (July 19, 2011) http://www.biopoliticaltimes.org/ 
article.php?id=5788. 
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contemplate that it gather personally identifiable information on 
individuals, like genetic profiles or even residential addresses or birthdates. 
The Clearinghouse is designed to serve as an interpreter, not an entity that 
conducts empirical research and collects personally identifiable 
confidential information on research subjects or patients. Certainly, 
however, were such information to be part of the Clearinghouse’s 
repository, oversight and compliance with requirements such as the 
Privacy Rule of the Health Insurance Portability and Accountability Act124 
and perhaps the Genetic Information Nondiscrimination Act125 might be 
necessary.126 
A third critique is that the role of the Clearinghouse is too limited. 
Reducing the potential harm of environmental threats to fetal 
development requires more than interpreting information and making it 
accessible. Scholars in the field of public health have in recent years called 
for much more comprehensive initiatives.127 Such initiatives include, as “an 
initial step, better management of information, including information 
vehicles,”128 but extend well beyond that. They include supplying “care 
specific to hazardous environmental exposures related to perinatal 
health.”129 They would also involve providing “guidance for medical 
education,”130 developing “[n]ational shared goals”131 as well as a 
 
 124. Office for Civil Rights, U.S. Dep’t of Health & Hum. Servs., Summary of the HIPAA 
Privacy Rule ii (2003) (“The Standards for Privacy of Individually Identifiable Health Information 
(‘Privacy Rule’) establishes, for the first time, a set of national standards for the protection of certain 
health information. The U.S. Department of Health and Human Services (‘HHS’) issued the Privacy 
Rule to implement the requirement of the Health Insurance Portability and Accountability Act of 
1996 (‘HIPAA’). The Privacy Rule standards address the use and disclosure of individuals’ health 
information—called ‘protected health information’ by organizations subject to the Privacy Rule— 
called ‘covered entities,’ as well as standards for individuals’ privacy rights to understand and control 
how their health information is used.”). 
 125. Pub. L. No. 110-233, 122 Stat. 881 (2008) (providing regulations on nondiscrimination based 
on personal genetic information in the contexts of insurance and employment). For information about 
GINA, see Genetic Information Nondiscrimination Act (GINA) of 2008, Nat’l Hum. Genome 
Research Inst., http://www.genome.gov/24519851 (last visited July 1, 2012). 
 126. An additional critique, or at least a question about the proposal, might involve why the 
Clearinghouse is limited to the intersection of threats of environmental toxicants and fetal 
development as opposed to childhood or adolescent development or adulthood. At least two 
responses merit mention. First, it appears that fetal development is a period of especially heightened 
susceptibility to environmental toxicants, as are embryonic (which would seem to fall within the 
Clearinghouse’s mission) and early childhood development (which exceeds the specific Clearinghouse 
mission). See, e.g., Grandjean, supra note 2. Second, an even broader mission for the entity would 
dilute its focus on fetal development and likely would require more extensive resources to succeed. 
 127. Grason & Misra, Reducing Exposure, supra note 19, at 637–40 (2009) (“We [describe] a wide 
range of policy strategies [including short-term actions and longer-term initiatives] that could be 
implemented to address environmental toxicants in the context of perinatal health.”).  
 128. Id. at 637. 
 129. Id. at 639. 
 130. Id. Grason and Misra recommend modeling “an organized system of information and care 
specific to hazardous environmental exposures related to perinatal health” on the “system used by 
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“prevention model that incorporates a lifespan perspective through 
primary (information and education), secondary (risk identification), and 
tertiary (counseling) prevention services”132 and “communication 
mechanisms that link all components and strengthen accountability . . . for 
improved outcomes for women and children consistent with the shared 
goals articulated.”133 Certainly, these scholars are correct that more 
comprehensive approaches will be needed to effectively grapple with 
reducing environmental threats to fetal development. But accurate, 
reliably interpreted, and accessible information about those potential 
threats and their implications supports and is arguably a prerequisite to 
significant progress in reducing those threats. The Clearinghouse could 
thus serve as the foundation for the advancement of more comprehensive 
initiatives. 
A fourth critique of the Clearinghouse relates to its Internet-based 
nature. Its online presence does allow for rapid and real-time updates of 
information, but not everyone has access to or uses computers to gather 
health information. For example, one study conducted in 1999–2000 
documented disparities in the use of Internet resources based on 
demographics.134 The researchers “conducted a population-based study to 
examine women’s use of health information resources.”135 They found 
that “women with higher incomes (>$50,000) had 2.2 times greater odds 
of using computer-based resources compared with women with a 
household income of ≤50,000.”136 In addition, their analysis indicated 
that, of the women surveyed, the White women were more likely than 
the Black women to use computer-based resources to access health 
information.137 With respect to computer access, the American Library 
Association reports that nearly “all of America’s 16,543 public library 
buildings offer free public access to computers, to the Internet and to 
trained staff equipped to help library users gain technology skills and find 
 
U.S. poison control centers.” Id. 
 131. Id. 
 132. Id. 
 133. Id. 
 134. Wanda K. Nicholson et al., The Relationship of Race to Women’s Use of Health Information 
Resources, 188 Am. J. Obstetrics & Gynecology 580 (2003) The study researchers noted that their 
“survey only asked whether the respondents used computer-based resources.” Id. at 584. The 
researchers did not ask “respondents about their access to computers through employment or family 
and friends.”Id. 
 135. Id. at 581. 
 136. Id. at 582. 
 137. Id. at 584. The researchers explain that this difference in the likelihood that the women 
surveyed would use computer-based resources to access health information manifested even after the 
researchers adjusted “for income, education, marital status, age, and employment in the logistic 
regression model,” id., with the Black women in the study “60% less likely than [the White] women to 
use computer-based resources.” Id. 
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the information they need.”138 This suggests that access to computer 
resources is improving. Even if public access becomes or is available, 
however, accessing personal health information in a public space may still 
not be an inviting prospect. Moreover, women may not use computers to 
obtain health information for reasons unrelated to computer access. But, 
even for women who may not personally use a computer to access health 
information, because it is in a public space or for other reasons, the 
establishment of the Clearinghouse may nonetheless augment their access 
to reliable and current evidence-based health information because some of 
these women may seek information from their health care providers, who 
will probably have access to a computer and may use the resources of the 
Clearinghouse. Still, the Clearinghouse should explore additional avenues 
for making its resources available to the public. 
Conclusion 
Extraordinary advances in neuroscience and related fields 
contribute to a growing understanding of the environmental threats that 
can impair fetal (and, consequently, often lifelong) health. As we learn 
more about these threats, often the desire as well as the ability to protect 
against the damage the threats may cause multiplies. In a world of 
information dearth and avalanche, informed and evaluative interpreters 
of information about fetal health become critical. For the mother I 
imagined at the start of this Article who had elevated levels of 
methylmercury, the proposed Clearinghouse could have equipped her 
with knowledge about the toxic properties of methylmercury from 
research beyond the reassuring recommendations about albacore tuna on 
the FDA and HHS websites. The Clearinghouse might have spared her 
child the impairments described, or at least—by equipping the mother 
with and enabling her to act on the best information available—spared 
her the unremitting uncertainty of a possible role in having caused her 
child’s impairments. The Clearinghouse proposed here responds to the 
need for informed, independent, and evaluative interpreters to transform 
the concurrent information inaccessibility and overload into accessible, 
interpreted, and useful databases that can effectively inform policy 
makers, pregnant women, physicians, and anyone else with an interest in 
or a need to know about environmental risks to fetal development. 
 
 138. See supra note 89. 
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